Schmertzler Michael

Cytokinetics Inc.

Avg. Two Year Performance

(32%) Avg. Purchase Return (15%) Compound

69% Avg. Sale Return 30% Compound

Holdings: 4.34M shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions